GlassScriptPhysician profile
George S Goetz
NPI 1366509978
$3,879.00
in general payments reported to CMS, 2019-2025
18 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $141 · 2021: $511 · 2022: $940 · 2023: $874 · 2024: $1,000 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,154.86 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $747.21 | 2020-2024 | Entyvio |
| Janssen Biotech, INC. | $624.32 | 2019-2025 | Stelara, Tremfya, Remicade |
| Celgene Corporation | $257.62 | 2021-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $248.09 | 2022-2024 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.81 | 2019-2024 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $182.50 | 2022-2023 | Zeposia |
| Qol Medical, LLC | $134.33 | 2022-2023 | Sucraid |
| Phathom Pharmaceuticals, INC. | $107.90 | 2024 | Voquezna |
| Genzyme Corporation | $94.00 | 2022-2023 | |
| Braintree Laboratories, INC. | $25.36 | 2021-2023 | Sutab, Suflave |
| Stryker Corporation | $17.72 | 2025 | Neptune, Pedi-Pom |
| Ardelyx, INC. | $15.07 | 2024 | Ibsrela |
| Integra Lifesciences Corporation | $14.84 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Lucid Diagnostics INC. | $14.70 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.52 | 2019 | |
| Medtronic, INC. | $11.79 | 2021 | |
| Allergan, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Goetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.